Brief: Biotec Pharmacon EBITDA Loss Narrows To NOK 1.6 Million

Arcticzymes Technologies ASA

30/01/2019 06:02

Jan 30 (Reuters) - Biotec Pharmacon ASA  BIOTEC.OL :
    * GROUP SALES WERE UP 10% TO NOK 19.5 MILLION IN Q4 2018 (Q4
2017:
NOK 17.7 MILLION)
    * Q4  ANNUAL SALES WERE NOK 66.8 MILLION (2017: NOK 66.7
MILLION)
    * EBITDA OF NOK -1.6 MILLION IN Q4 (Q4 2017: NOK -7.2
MILLION)
    * OPERATING EXPENSES FOR Q4 DECREASED TO NOK 18.5 MILLION
(Q4
2017: NOK 19.9 MILLION)

Source text for Eikon:  ID:nObiwgfq5a 
Further company coverage:  BIOTEC.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))